Portfolio

Established in 2003, ECN utilizes advanced industry knowledge, practices, and technology to move clinical trials efficiently from mandate to completion across a broad spectrum of therapeutic areas for pharmaceutical companies and contract research organizations. ECN is a leader in rapid protocol patient acquisition and currently operates a dedicated network of 14 research sites, with more in development across the United States. These sites offer a range of physician specialties and a proprietary database of over 100k research study candidates, which is closely monitored by the corporate management team. ECN often satisfies sponsor enrollment goals for clinical trials within six months of activation, which allows sponsors to quickly launch new vaccines and drugs while reducing costs.